… fraction of people with Parkinson’s develop the disease from a genetic mutation, researchers like Inga Peter, PhD, a … the Icahn School of Medicine at Mount Sinai, are learning from those who do carry these genetic traits. With support from MJFF , Dr. Peter is identifying a combination of …

… test is the latest, and most significant, finding to date from the study.  Today, with this discovery in hand, Parkinson’s is moving from a disease primarily understood, diagnosed and measured … such as αSyn-SAA, is supported by major funding from Aligning Science Across Parkinson’s (ASAP), a …

… to get off the ground, they would need significant support from funders willing to champion new approaches. Meanwhile, … Sherer, PhD, the Foundation’s CEO. “He wanted to diverge from the classical pursuit of treatments targeting the … debilitating side effects like dyskinesias.” With funding from the Foundation starting in 2005, Conn’s team at …

… a decision for you and your care team, ideally with input from a movement disorder specialist.   For now, perhaps the … biopsy detected misfolded alpha-synuclein in skin samples from 92.7 percent of confirmed PD patients in the study.  It … have the ability to change the research landscape, and your buy-in moves them forward.   David Kumbroch Director, …

… treatments that could slow, or even stop, the disease from progressing in patients’ brains and bodies. Last fall, we had the opportunity to convene a workshop to address a budding hypothesis in the field — that the … abnormally in the brains of all people with PD, spreads from cell to cell. This evidence is providing us with new …

… in several months of self-prescribed medication boosted from my mother’s pharmaceutical stash, I caved to family … announced that he was going with me, presumably to keep me from veering off course and hitting up the Nordstrom fall … on the small of my back to keep my feet pointed  away  from the exit. The door opened and a pretty, young doc (I’m …